The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
and the studies that have come out from him and his group and I respect that group we we can see some relative increases in anxiety in some of those patients but overall the studies have been pretty good about showing this we don't we're not seeing any proclivity towards dementia with these patients or proclivity towards Lewy Body or poor clivity towards other neurodegenerative illnesses
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.